RSS Feed
Twitter
6:38 AM
CJ
Every time I purchase a stock, I make myself write down why I thought it would be a good idea to make the purchase.
* Disclaimer: This article is in no way a solicitation to buy, sell, or trade for the stock. It is just my analysis of my thought process when I purchased the stock. *
Stock Name: BioDelivery Sciences International
Stock Ticker: BDSI
Purchase Date: (Initial) March 13, 2013
Purchase Amount: 25 shares @ $4.10
Additional Purchases:
April 5, 2013 - 25 shares @$4.25
Mindset during initial purchase:
A while back I read about a health care stock that was pretty inexpensive and was considered to be a "takeover candidate". I bought a bunch of shares and a few months later, the stock price doubled when they were bought out by another company.
I read an article about BDSI that pretty much echoed the same situation as described above. BioDelivery Sciences International is a healthcare company that focuses on therapeutics in pain management and oncology supportive care.
In lay terms, the company supports pain management for folks with tumors and cancers. Both of those horrific conditions are rampant in the world today.
Stock analyst company/website Zach's gave BDSI a rating of #2, or buy.
CNN Money's forecast (at the time of my initial purchase) had a low of $5, medium of $7.63, and a high of $11.
"Piper Jaffray" had recently upgraded the stock to overweight.
Lessons Learned from Purchasing This Stock
One of the neat things about purchasing this stock was that I learned the meaning of the phrase "overweight". I'm learning to force myself to research the little details about a stock, instead of just assuming I know what the articles are talking about.
Overweight, when talking in the financial industry, means that the stock is considered to be a better value for your money than other stocks.
* Disclaimer: This article is in no way a solicitation to buy, sell, or trade for the stock. It is just my analysis of my thought process when I purchased the stock. *
Stock Name: BioDelivery Sciences International
Stock Ticker: BDSI
Purchase Date: (Initial) March 13, 2013
Purchase Amount: 25 shares @ $4.10
Additional Purchases:
April 5, 2013 - 25 shares @$4.25
Mindset during initial purchase:
A while back I read about a health care stock that was pretty inexpensive and was considered to be a "takeover candidate". I bought a bunch of shares and a few months later, the stock price doubled when they were bought out by another company.
I read an article about BDSI that pretty much echoed the same situation as described above. BioDelivery Sciences International is a healthcare company that focuses on therapeutics in pain management and oncology supportive care.
In lay terms, the company supports pain management for folks with tumors and cancers. Both of those horrific conditions are rampant in the world today.
Stock analyst company/website Zach's gave BDSI a rating of #2, or buy.
CNN Money's forecast (at the time of my initial purchase) had a low of $5, medium of $7.63, and a high of $11.
"Piper Jaffray" had recently upgraded the stock to overweight.
Lessons Learned from Purchasing This Stock
One of the neat things about purchasing this stock was that I learned the meaning of the phrase "overweight". I'm learning to force myself to research the little details about a stock, instead of just assuming I know what the articles are talking about.
Overweight, when talking in the financial industry, means that the stock is considered to be a better value for your money than other stocks.
Posted in 
0 comments:
Post a Comment